






































































Highly efficient transfer hydrogenation catalysis with tailored pyridylidene 
amide pincer ruthenium complexes  
 
 
Philipp Melle,1 Jan Thiede,1 Daniela A. Hey,1,2 and Martin Albrecht*,1 
 
 
In memoriam Anneke Krüger 
 
1 Department für Chemie und Biochemie, Universität Bern, Freiestrasse 3, CH–3012 Bern, Switzerland. 
2 Fakultät für Chemie, Technische Universität München, Lichtenbergstrasse 4, 85748 Garching, Germany 
* email: martin.albrecht@dcb.unibe.ch 
 
 





The rational optimization of homogeneous catalysts requires ligand platforms that are easily tailored to 
improve catalytic performance. Here, we demonstrate that pyridylidene amides (PYAs) provide such a 
platform to custom-shape transfer hydrogenation catalysts to exceptional activity. Specifically, a series of 
meta-PYA pincer ligands with differently substituted PYA units has been synthezised and coordinated to 
ruthenium(II) centres to form bench-stable tris-acetonitrile complexes [Ru(R-PYA-pincer)(MeCN)3](PF6)2 
(R = OMe, Me, H, Cl, CF3). Analytic studies including 1H NMR spectroscopy, cyclic voltammetry, and X-
ray crystallography reveal a direct influence of the substituents on the electronic properties of the ruthenium 
center. The complexes are active in the catalytic transfer hydrogenation of ketones, with activities directly 
encoded by the PYA substitution pattern. Their perfomance improves further upon exchange of an ancillary 
MeCN ligand with PPh3. While complexes [Ru(R-PYA-pincer)(PPh3)(MeCN)2](PF6)2 were only isolated 
for R = H, Me, an in situ protocol was developed to generate these complexes in situ for R = OMe, Cl, CF3 
by using a 1:2 ratio of the complexes and PPh3. This in situ protocol together with a short catalyst pre-
activation provided highly active catalytic systems. The most active pre-catalyst featured the methoxy-
substituted PYA ligand and reached turnover frenquencies of 210,000 h–1 under an exceptionally low 
catalyst loading of 25 ppm for the benchmark substrate benzophenone, representing one of the most active 





Advanced ligand design has become a key technology to improve homogeneous catalysts. Specifically, the 
development of cooperative ligands that undergo chemical transformation synergistically with the metal 
center has enabled numerous transformations with unrivalled efficiency.[1–8] In a complementary approach, 
considerable progress has been achieved with ligands that feature ambiguous donor properties. 
N-Heterocyclic carbenes (NHC) may be considered a prime example of this class of donor-ambiguous 
ligands, as NHCs feature a neutral L-type carbene resonance structure as well as an zwitterionic ylid 
resonance form, which imparts an anionic X-type metal coordination (A, Fig. 1).[9–12] Although rarely 
discussed in this context, this donor ambiguity of NHCs may be relevant for the high catalytic activity that 
these ligands often entail. A growing number of related ligand systems with a similarly ambiguous 
coordination motif has evolved from this scaffold, including for example mesoionic NHCs,[13,14] and 
N-heterocyclic olefins (B).[15–20] In more recent years, this concept has been expanded from C-donors to 
N-donor ligands as competitive alternatives to NHCs.[21] In particular Alcarazo-type ligand scaffolds 
combining a metal-bound imine as part of a guanidine derivative (C), or bound to a benzimidazolylidene or 
cyclopropenyl scaffold have shown promising donor properties.[22,23] A related ligand class are the so-called 
pyridylidene amides (PYAs, D)[24] and pyridylidene amines (PYEs),[25–27] which feature a neutral imine 
resonance structure with L-type metal coordination, as well as a zwitterionic pyridinium amide resonance 
form. These ligands were demonstrated to adapt their donor properties in response to the external 
environment, such as solvent polarity, and to the electronic configuration of the metal center, which ensues 
stabilization of different metal oxidation states.[28–30] As a consequence of these unique and flexible donor 
properties, PYA ligands have been successfully applied in a variety of catalytic transformations with 
appealing performances.[28–36] 
  































PYAs are a particularly attractive sub-class of donor-flexible ligands because of their easy accessibility and 
their synthetic versatility, which provides ample opportunities for ligand modifications. PYA variation has 
focused predominantly on modulation of the amide substituent R, including the incorporation of chelating 
groups,[24,28–30,35,37] as well as the positioning of the pyridinium site.[26,31,34,35] Remarkably, however, the 
synthetic versatility of pyridines has not been explored so far, even though such modifications are bound to 
have a direct impact on the donor properties of the PYA ligand. Here, we have introduced substituents on 
the PYA heterocycle in meta-PYA pincer-type ligands and demonstrate that their electronic influence 
directly affects the catalytic properties of the coordinated ruthenium center. We have exploited this 
methodology to develop highly active transfer hydrogenation catalysts, which reach turnover frequencies of 
more than 200,000 h–1 and operate at unusually low catalyst loadings in the ppm range, thus providing a 
catalytic system that offers an attractive alternative to other high-performance catalysts. 
 
Results and discussion 
Synthesis of substituted PYA pincer ruthenium complexes. The dicationic ligand salts L1–5 were 
synthesized according to slightly modified literature procedures[38] starting from 2-substituted 5-
aminopyridines and 2,6-pyridinedicarbonyl dichloride (Scheme 1). Amidation gave the substituted 
bis(amides) pre-L1–5 in good 70–90% yields,[39] and subsequent methylation afforded the ligand precursors 
L1–5. Successful methlyation required an excess of MeOTf as a strong alkylating reagent rather than MeI, 
which was used for preparing the unsubstituted meta-PYA pincer ligand L3.[35] With MeI, an inseparable 
mixture of mono- and bis-alkylated products formed. Anion exchange from OTf– to PF6– was accomplished 
with an excess of NH4PF6 in a MeCN/H2O solvent mixture, as indicated by HR ESI-MS analysis through 
detection of the monocationic ligand species, e.g. [M–PF6]+ at 554.1387 amu for L1 (calcd. 554.1386). 
 
Scheme 1. General synthesis of the para-substituted meta-PYA pincer ligands, complexation to ruthenium, and 










































a   (MeCN)3
b   (PPh3)(MeCN)2






(ii) 3 eq. MeOTf, CH2Cl2, reflux, 16 h; then 5 eq. NH4PF6, H2O/MeCN. (iii) 0.5 eq. [RuCl2(cym)]2, 3 eq. Na2CO3, 
MeCN, reflux, 16 h. (iv) 1.1 eq. PPh3, EtOH, reflux 16 h. (v) 1.1 eq dppe, EtOH, reflux, 16 h. 
 
Ruthenation of the ligand precursors L1–5 was carried out with [RuCl2(cym)]2 under basic conditions (cym 
= p-cymene)[35] and gave the octahedral ruthenium(II) PYA pincer complexes 1a–5a with ancillary MeCN 
ligands. The crude complexes were purified by conventional column chromatography to give analytically 
pure orange solids that were bench-stable for several weeks without requiring any protection from air or 
moisture. Ligand coordination to the RuII center resulted in the loss of the low-field NH amide proton 
resonances and in a marked upfield shift of the aromatic H6PYA proton resonances, e.g. from dH = 9.26 in L1 
to 8.49 in complex 1a. The three coordinated MeCN ligands gave two sets of singlets in 2:1 integral ratio, 
in agreement with two chemically equivalent axially coordinated MeCN entities and one equatorial MeCN 
coordinated in the PYA pincer plane. 
Heating of the tris-acetonitrile complex 2a comprised of a methyl-substituted PYA ligand in an ethanolic 
solution with a slight excess of PPh3 or dppe (dppe = 1,2-diphenylphosphinoethane) afforded the 
monophosphine complex 2b and the dppe analogue 2c, respectively (Scheme 1). Remarkably, all attempts 
to isolate the phosphine variants of complexes 1, 4 or 5 (R = OMe, Cl, CF3) have been unsuccesful thus far. 
Neither modification of the synthetic procedure such as avoiding protic solvents, nor using lower 
temperatures or inert atmosphere, nor varying the phosphine equivalents gave the desired complexes. 1H 
NMR analysis of the crude products showed broad paramagnetic signals and attempts to isolate the formed 
products only gave insoluble black solids. We speculate that the Ru(II) complexes undergo a slow 
irreversible oxidation to form meta-stable Ru(III) species under the applied conditions. 
 
Spectroscopic, electrochemical, and structural analysis of the impact of the PYA substituents. The 
electronic impact of the different PYA substituents of complexes 1a–5a was indicated by a direct correlation 
of the 1H NMR chemical shifts of H3 and H6 of the PYA ligand with the Hammett parameter sp of the 
corresponding substituent (Fig. S21, Table 1).[40] For example, the H3PYA resonance shifts from dH = 7.37 in 
complex 1 bearing a methoxy substituent (sp = –0.27) downfield to dH = 7.84 in complex 3a with an 
unsubstituted meta-PYA ligand (sp = 0) and to dH = 8.27 in complex 5a featuring an electron-withdrawing 
CF3 substituent (sp = +0.54). A similar shift range of DdH = 0.76 was observed for the H6PYA resonance, 
while the H4PYA signal was unaffected, presumably due to H-bonding to the amide C=O fragment. 
Whereas NMR spectroscopic data is limited to probe ligand-based electronic properties, cyclic voltammetry 
(CV) measurements provide a method to evaluate the electron density at the metal center. Complexes 1a–
5a show a reversible redox process around 0.5 V (vs SSCE) and a second, quasi-reversible process around 
1.7 V (Fig. 2a, Fig. S22, S23), which have been attributed to RuII/III and RuIII/IV transitions. The half-wave 
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potentials (E1/2) for the RuII/III oxidation indicate a direct influence of the substituent R on the oxidation 
potentials of complexes 1a–5a. They gradually increase as the PYA substituent becomes less donating from 
0.60 V for 1a (R = OMe) to 0.66 V (complexes 2a and 3a, R = Me, H), 0.68 V (complex 4a, R = Cl) and to 
0.77 V (complex 5a, R = CF3). The qualitative correlation of the redox potential with the Hammett parameter 
sp (Fig. 2b) indicates that the electron density at the metal center is rationally tailored by an appropriate 
choice of the substituent R in these PYA pincer ligands, revealing a substantial impact of synthetically 
simple ligand modifications. Moreover, it is remarkable that the potential window for the RuII/III process 
(DE1/2 = 170 mV between R = OMe and R = CF3) is considerably amplified for the RuIII/IV transition (DE1/2 
= 310 mV).  
 














Figure 2. a) Cyclic voltammetry measurements of complexes 1a (red), 3a (green), and 5a (purple) in MeCN (1 mM 
complex conc., potentials vs. SSCE using the Fc+/Fc couple as standard; E1/2 = +0.4319 and n-Bu4NPF6 as electrolyte, 
100 mVs-1 scan rate). b) Redox potentials vs. sp for complexes 1a–5a. 
 
Further support for the influence of the ligand system on the complex properties was gained by UV-vis 
spectroscopy (Fig. S24). The characteristic metal-to-ligand charge transfer (MLCT) bands in the visible 
region of the spectra (390–420 nm range) shift gradually to lower energy as the R-substituent becomes more 
electron withdrawing, in agreement with a lower energy of the ligand π* MOs and thus a smaller d−π* gap. 
Low-energy MLCT transitions indicate p-acidic properties of the PYA ligand and hence a pronounced imine 
rather than amide resonance form and L-type coordination (cf Fig. 1) when functionalized with electron-
withdrawing Cl or CF3 substituents. 
 























Table 1. Selected 1H NMR, UV-vis spectroscopic and electrochemical data for complexes 1a–5a 
a in CD3CN at 298 K, 300 MHz. b in MeCN solutions (50–100 µM Ru complex). c in MeCN containing 0.1 M 
nBu4N(PF6) as supporting electrolyte at 100 mV s–1 scan rate, potentials vs. SSCE using Fc+/Fc as internal standard at 
E1/2 = +0.4319 (ref [56]). 
 
Single crystals of complexes 1a and 5a were analyzed by X-ray diffraction. The molecular structures 
confirmed the octahedral geometry of the Ru(II) center and the connectivity pattern deduced from solution 
analysis (Fig. 3). Both structures show meridional coordination of the PYA pincer ligand and bonding of 
three MeCN ligands, with very similar bond distances around the metal center, i.e. little structural variation 
is imparted by the electronic nature of the PYA substituents (Table 2). The PYA pincer bite angle is identical 
in both complexes (157.13(5)° and 157.41(7)° for 1a and 5a, respectively), and equal to the unsubstituted 
analogue 3a (157.55(8)°). Notably, the OMe-substituted PYA heterocycles in complex 1a are substantially 
twisted out of the plane of the central pyridine ring (q = 45.5° and 47.9°) compared to complex 3a with no 
substituent (q = 34.9° and 41.8°)[35] and complex 5a featuring CF3 groups (q = 29.4° and 42.6°). A larger 
dihedral angle indicates a low p contribution to the NPYA–Cpyridyl bond (N1–C3) and hence only little 
conjugation between the PYA heterocycle and the metal-bound amide nitrogen. Consequently, the amide 
nitrogen is predominantly acting as an anionic X-type N-donor ligand, a feature that is most pronounced in 
complex 1a with strongly donating OMe substituents and least with electron-withdrawing CF3 groups on 
the PYA unit.  
 
 
entry complex R (L1)(L2)(L3)    sp d [ppm]a lmax [nm]b E1/2 [V]
c 
     H3 H6  RuII/III RuIII/IV 
1 1a OMe (MeCN)3 –0.27 7.37 8.49 393 0.60 1.67 
2 2a Me (MeCN)3 –0.17 7.70 8.83 397 0.66 1.79 
3 3a H (MeCN)3   0.00 7.84 8.91 402 0.66 1.81 
4 4a Cl (MeCN)3   0.23 7.92 9.03 405 0.68 1.83 
5 5a CF3 (MeCN)3   0.54 8.27 9.25 416 0.77 1.98 
8 
Figure 3. ORTEP representations of the complex cations 1a (a) and 5a (b); all ellipsoids at 50% probability level 
(hydrogen atoms, non-coordinating PF6– anions and co-crystallized solvent molecules omitted for clarity). 
 
Table 2. Selected bond lengths (Å) and angles (deg) for complexes 1a, 3a, and 5a 
a from ref [35]. b	dihedral angle q between the PYA heterocycle and the N–C=O amide plane. 
 
Transfer hydrogenation catalysis with isolated complexes. All isolated complexes 1a–5a were evaluated 
as catalyst precursors in transfer hydrogenation of benzophenone as model substrate. Under standard 
conditions (substrate/base/catalyst in 100:10:1 ratio in refluxing iPrOH),[41] all reactions went to completion 
within 1 h or less. The time-conversion profiles revealed turnover frequencies at 50% conversion, TOF50, 
around 500 h–1 for all complexes, though the unsubstituted complex 3a featured a short induction period 
(Fig. 4, Table 3). 
 


















Figure 4. Time-conversion profiles for the transfer hydrogenation of benzophenone with complexes 1a (red), 2a 
(yellow), 3a (green), 4a (blue) and 5a (purple). Reaction conditions: benzophenone (0.5 mmol), KOH (0.05 mmol, 
10 mol%), cat. (0.005 mmol, 1 mol%), iPrOH (10 ml), N2 atmosphere, reflux temperature. 
 1a 3aa 5a 
Ru1–N1 2.120(2) 2.106(2) 2.137(2) 
Ru1–N2 1.966(1) 1.959(2) 1.964(2) 
Ru1–N3 2.108(2) 2.114(2) 2.120(2) 
Ru1–N4 2.009(2) 2.024(2) 2.022(2) 
Ru1–N5 2.053(1) 2.056(2) 2.051(2) 
Ru1–N6 2.015(2) 2.010(2) 2.022(2) 
N1–Ru1–N3 157.13(5) 157.55(8) 157.41(7) 
q PYA–pyr b 45.5; 47.9 34.9; 41.8 29.4; 42.6 
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Exchange of ancillary MeCN ligands by phosphines further enhanced the catalytic activity and allowed for 
reducing the catalyst loading to 0.1 mol% (entries 6–9). While the MeCN complex 2a gave only slow 
conversion at this S/B/C ratio of 1000:10:1 (33% after 0.5 h; Fig. 5), introduction of dppe raised the activity 
markedly and complex 2c reached 62% conversion within this time frame, corresponding to a 2-3 times 
better performance. Complex 2b containing an ancillary PPh3 ligand was even more active and reached full 
conversion within 30 min (TOF50 around 7,000 h–1). This activity is more than one order of magnitude 
higher than the MeCN analogue 2a. This result underpins the benefits from combining the donor flexible 
PYA pincer scaffold with the strong trans effect of phosphine ligands[35,42] for efficient transfer 
hydrogenation catalysis.  
 



















Figure 5. Time-conversion profiles for the transfer hydrogenation of benzophenone with complexes 2a (orange), 2b 
(cyan) and 2c (light green) at 0.1 mol% catalyst loading. Reaction conditions: benzophenone (5.0 mmol), KOH 
(0.05 mmol, 10 mol%), cat. (0.005 mmol, 1 mol%), iPrOH (10 ml), N2 atmosphere, reflux temperature. 
 
Table 3. Catalytic activity of isolated PYA pincer ruthenium complexes in transfer hydrogenation of benzophenone.a 
 
entry [Ru] R (L1)(L2)L3) loading [mol%] conversion [%]b TOF50 [h–1]c 
     5 15 30 60 min  
1 1a OMe (MeCN)3 1 38 93 96 >99 470 
2 2a Me (MeCN)3 1 30 80 94 >99 380 
3 3a H (MeCN)3 1 17 86 96 >99 340 
4 4a Cl (MeCN)3 1 39 95 >99 >99 480 
10 
5 5a CF3 (MeCN)3 1 37 92 98 >99 470 
6 2a Me (MeCN)3 0.1 n.d. n.d. 33 92 500 
7 2b Me (PPh3)(MeCN)2 0.1 56 93 >99 >99 6,900 
8 2c Me (dppe)(MeCN) 0.1 n.d. 35 61 >99 1,300 
9 3b H (PPh3)(MeCN)2 0.1 37 77 95 >99 4,000 
a General reaction conditions: benzophenone (0.5 or 5.0 mmol), KOH (0.05 mmol), [Ru] cat. (0.005 mmol), iPrOH 
(10 mL), N2 atmosphere, reflux temperature. b Determined by 1H NMR spectroscopy using hexamethylbenzene as 
internal standard and averaged over two runs (less than 10% deviation), conversions correspond to yields; n.d. = not 
determined. c see SI for TOF calculations. 
 
Transfer hydrogenation catalysis with in situ formation of PPh3 complexes. Since all attempts to isolate 
the phosphine complexes [Ru(R-PYA-pincer)(PPh3)(MeCN)2]2+ failed when the PYA unit was substituted 
with a OMe, Cl, or CF3 group, an in situ methodology was developed to access complexes 1b, 4b, and 5b 
for catalytic application. Such in situ strategies are widely used in homogeneous catalysis, e.g. in high 
throughput ligand screening[43–45] or when generating highly unstable catalytic systems.[46,47] The in situ 
methodology was validated with the tris-MeCN complex 3a and compared with the catalytic activity of the 
analogous isolated PPh3 complex 3b at a S/B/C ratio of 1000:10:1 (Fig. 6). Thus, a catalytic run with 
complex 3a in the presence of 2 eq. PPh3 afforded a catalytic profile that is comparable to that of isolated 
complex 3b apart from a short induction period, indicated by a mere 9% conversion after 5 min compared 
to 37% with the preformed complex 3b. After this induction period, both catalytic systems showed 
essentially identical performance. Enhancing the phosphine concentration to 10 eq. gave lower conversion 
rates than with 2 equivalents. Presumably, competitive metal bonding disfavors substrate coordination and 
leads to complexes with more than one phosphine ligand, which lowers the catalytic performance (cf dppe 
complex 3c and proposed mechanism in Scheme S1). This model is supported by the considerably lower 
activity when complex 3b was used in the presence of 10 eq. PPh3. The induction time was effectively 
suppressed, however, when complex 3a was pre-activated with 2 eq. PPh3 at 70°C for 10 min. These 
conditions reproduced the catalytic performance of the isolated complex 3b very well and were therefore 
applied for catalysis with complexes 1a–5a to generate complexes 1b–5b in situ.  
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Figure 6. Time-conversion profiles for experiments carried out in order to find the best protocol for the in situ 
formation of catalyst 3b starting from 3a. General reaction conditions: benzophenone (5.0 mmol), KOH (0.05 mmol, 
1 mol%), complex (0.005 mmol, 0.1 mol%), PPh3 (varying amounts), iPrOH (10 ml), N2 atmosphere, reflux 
temperature. 
 
All pre-activated and in situ generated complexes 1b–5b are considerably more active than the 
phosphine-free parent complexes 1a–5a, and although the catalyst loading was reduced tenfold from 1 to 
0.1 mol%, full conversion of benzophenone was achieved in much shorter reaction times than in the absence 
of PPh3 at higher catalyst loading (Fig. 7, Table 4). For example, full conversion with complex 1a requires 
more than 30 min at 1 mol% loading in the absence of PPh3 (cf Table 3, entry 1), while the reaction is 
complete within 5 min at 0.1 mol% loading when 2 eq. PPh3 were added (Table 4, entry 1). The activity of 
this system (TOFmax about 20,000 h–1) is almost two orders of magnitude higher than in the absence of 
phosphine (TOFmax around 500 h–1, cf Table 3). Pre-activation enhances the initial activity, though the 
maximum activity is unaltered (Table S1). Notably, the PYA substituents have a profound effect on the 
catalytic activity of the phosphine-activated complex. While a Me substituent did not change the activity of 
the ruthenium center significantly compared to the unsubstituted system, the CF3 group in 5b induced a 
twice higher activity, and complexes 1b and 4b with OMe and Cl substituents, respectively, displayed the 
highest activity of this series and reached TOFmax around 20,000 h–1. Obviously, the activity change is not 
governed solely by the Hammett sp parameters of the different substituents and instead, other factors like 
inductive effects may play a significant role for catalytic turnover. 
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Figure 7. Time-conversion profiles for the transfer hydrogenation of benzophenone with in situ formation of 
PPh3-complexes after pre-activation of the complex in the presence of 2 moleq. PPh3 for 10 min at 70°C, 1b (red), 2b 
(yellow), 3b (green), 4b (blue) and 5b (purple). Reaction conditions: benzophenone (5.0 mmol), KOH (0.05 mmol, 
1 mol%), cat. (0.005 mmol, 0.1 mol%), PPh3 (0.01 mmol, 0.2 mol%) iPrOH (10 ml), N2 atm., reflux temperature. 
 
Table 4. Catalytic activity in transfer hydrogenation of benzophenone for in situ formed complexes 1b–5b.a 
 
entry [Ru] R  conversion [%]b TOFmax [h–1] 
    1’ 2’ 2.5’ 5’ 15’  
1 1b OMe  13 45 n.d. >99 >99 19,000 
2 2b Me  n.d. n.d. 27 54 96 6,500 
3 3b H  n.d. n.d. 9 32 89 5,500 
4 4b Cl  5 29 n.d. 91 95 14,000 
5 5b CF3  n.d. 11 n.d. 56 92 8,400 
a General reaction conditions: benzophenone (5.0 mmol), complex 1a–5a (0.005 mmol, 0.1 mol%), PPh3 
(0.01 mmol, 0.2 mol%) iPrOH (15 mL), N2 atmosphere, at 70°C for 10 min, then KOH (0.05 mmol, 1 mol%), reflux 
temperature. b Determined by 1H NMR spectroscopy using hexamethylbenzene as internal standard and averaged over 
two runs (less than 10% deviation), conversions correspond to yields. 
 
Catalytic transfer hydrogenation with complex 1b. Since complex 1b with OMe-substituted PYA units 
showed the highest catalytic activity within the series, it was used to optimize catalyst performance (Table 
5). Benzophenone was still converted fully within 15 min when the catalyst loading was lowered by one 
order of magnitude to 0.01 mol% (entry 2). At 0.005 mol% catalyst loading full conversion required a twice 
longer reaction time (entry 3), and the time-conversion profile is almost identical to the reaction with 
13 
0.01 mol% of complex 1 (Fig. S26). Even at 0.0025 mol% catalyst loading (25 ppm) essentially full 
conversion was reached after 2 h (entry 4). Under these conditions, the TOFmax was 210,000 h–1, one of the 
highest activities noted for transfer hydrogenation and comparable to benchmark systems developed by 
Morris[48] (amine(imine)diphosphine iron complex, TOF = 140,000 h–1 for benzophenone) or Baratta[49] 
(RuX(CO)(dppp)(NN)]Cl, TOF = 250,000 h–1 for benzophenone). At a 10 ppm catalyst loading 
(0.001 mol%), conversion was substantially compromised and incomplete even after prolonging the reaction 
to 24 h, plateauing at 80% conversion (TON = 80,000, entry 5). The high TONs suggest a remarkable 
longevity of the catalytically active species, presumably imparted by the tridentate coordinating PYA pincer 
ligand. Similarly high TONs were reported with related tridentate ligands bound to ruthenium featuring 
either an S,N,Te-bonding motif (TON = 96,000)[50] or a CNC pincer-type bis(carbene) complex (TON = 
126,000).[51] While attempts to also lower the base concentration from 1 to 0.1 mol% KOH resulted in 
negligible conversions even after longer reaction times (Fig. S26), the protocol is not restricted to 
benzophenone and also aliphatic and mixed aryl-alkyl ketones are successfully transfer hydrogenated with 
the the in situ formed complex 1b (Fig. S27). 
 
Table 5. Catalytic transfer hydrogenation activity of in situ formed complex 1b towards benzophenone reduction a 
entry 1b [mol%] time to equilibriumb max. conversion [%]b TOFmax [h–1] final TON b 
1 0.1   5 min > 99  19,000 > 990 
2 0.01 15 min > 99 90,000 > 9,900 
3 0.005 30 min > 99 180,000 > 19,800 
4 0.0025   2 h 98 210,000 39,200 
5 0.001 24 h 80 100,000 80,000 
a General reaction conditions: benzophenone (10.0 mmol), cat. 1b (x mol%), PPh3 (2x mol%) iPrOH (15 mL), N2 
atmosphere, 70°C for 10 min, then KOH (0.1 mmol, 1 mol%), reflux temperature. b Determined by 1H NMR 
spectroscopy using hexamethylbenzene as internal standard and averaged over two runs (less than 10% deviation), 
conversions correspond to yields. 
 
Conclusions 
Here, we demonstrate that modification of the PYA pincer ligand platform with substituents on the PYA 
fragment provides an efficient methodology for substantially improving ruthenium-catalyzed transfer 
hydrogenation. The introduction of substituents combined with an in situ protocol for the preparation of 
phosphine-containing complexes produces highly active systems that surpass the activity of the 
unsubstituted parent compounds by up to two orders of magnitude, reaching turnover frequencies around 
200,000 h–1, which is competitive to other state-of-the-art ruthenium-based catalysts. Moreover, the PYA 
pincer ruthenium complexes are active even at exceptionally low catalyst loading of 25 ppm. The 80,000 
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TON achieved with these complexes indicates a long-living catalytically active species. We speculate that 
the donor flexibility of the PYA ligand is particularly beneficial for accessing several transition states on 
the catalytic cycle and for stabilizing coordination of both neutral ketone and anioic hydride ligands required 
for classic monohydride transfer hydrogenation. The high catalyst performance is in line with the demanding 
requirements for precious metal catalysts and allows them to be used in small quantities only, underlining 
the potential of suitable ligand tailoring.  
 
Experimental 
General. All reagents were commercially available and used as received. Compounds L3, and 3a–c were 
synthesized according to previously described procedures.[35] Unless specified otherwise, NMR spectra were 
recorded at 298 K on Bruker spectrometers operating at 300 or 400 MHz (1H NMR), and 100 MHz (13C{1H} 
NMR), respectively. Chemical shifts (δ in ppm, coupling constants J in Hz) were referenced to residual 
solvent signals (1H, 13C). Assignments are based on homo- and heteronuclear shift correlation spectroscopy. 
Purity of bulk samples of the complexes has been established by NMR spectroscopy, and when possible by 
elemental analysis. Elemental analyses were performed at DCB Microanalytic Laboratory using a Thermo 
Scientific Flash 2000 CHNS-O elemental analyzer. High-resolution mass spectrometry was carried out with 
a Thermo Scientific LTQ Orbitrap XL (ESI-TOF) by the mass spectroscopy group of the Department of 
Chemistry and Biochemistry, University of Bern. UV/Vis measurements were performed on a UV-1800 
spectrometer (Shimadzu) with 1 cm quartz cuvettes. Cyclic voltammograms were recorded using an Autolab 
PGSTAT101 from Metrohm in MeCN solutions using 10 mL solvent, 1 mM sample, and 100 mM 
tetrabutylammonium hexafluorophosphate (nBu4N)PF6 as supporting electrolyte. Solutions were degassed 
with Ar gas for 10 min prior to each run. The scan rate was 100 mV s–1. Redox potentials were measured 
using a Pt-button working electrode, an Ag/AgCl reference electrode (SSCE) and a Pt-wire auxiliary 
electrode and are tabulated versus a ferrocene internal standard. The Fc+/Fc couple is 0.43 V vs. SSCE in 
0.1 M (nBu4N)PF6 MeCN solutions.[56] 
General procedure for the synthesis of ligands L1–5. 2-6-Pyridinedicarbonyldichloride (1 eq.) 
and the corresponding 5-amino-2-substituted-pyridines (2.1–2.5 eq.) were heated to reflux in toluene under 
vigorous stirring for 3 h. After cooling to room temperature, the formed suspension was filtered and the 
residue washed with acetone, saturated NaHCO3 solution, water, and again acetone. The resulting solid was 
dried at 80 °C and used for the methylation step without further purification. The solid was dissolved in dry 
CH2Cl2 under N2 atmosphere and MeOTf (3 eq.) was added carefully. After heating the reaction mixture to 
reflux for 3–16 h, the reaction mixture was cooled to room temperature and residual MeOTf was quenched 
by adding MeOH (2–3 mL). The resulting precipitate was filtered, washed with small portions of CH2Cl2 
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and Et2O, and air dried. This solid was then dissolved in a minimum amount of MeCN, and a solution of 
NH4PF6 (5 eq.) in H2O (twice the volume of MeCN) was added. The formed suspension was heated to reflux 
until a clear solution formed and then slowly cooled to room temperature, which resulted in the formation 
of crystals. After cooling to 6 °C for another 16 h, all crystals were filtered, washed with small portions of 
cold H2O, and dried at 80 °C. 
Compound L1. According to the general procedure starting from 2,6-pyridinedicarbonyldichloride 
(818 mg, 4 mmol) and 5-amino-2-methoxypyridine (1045 mg, 8.4 mmol) in toluene (60 mL) giving the bis-
amide N2,N6-bis(6-methoxypyridin-3-yl)pyridine-2,6-dicarboxamide as a purple powder (1208 mg, 80%). 
Refluxing the bis-amide (1139 mg, 3.0 mmol) in dry CH2Cl2 (100 mL) with MeOTf (1.0 ml, 9 mmol) for 
16 h gave L1 as OTf salt (1621 mg, 75%). Reaction of this triflate salt (354 mg, 0.5 mmol) in MeCN (6 mL) 
with aqueous NH4PF6 (411 mg, 2.5 mmol) gave L1 as light purple crystals (220 mg, 63%). 1H NMR 
(300 MHz, CD3CN, 298 K): d [ppm] = 10.36 (s, 2H, NHamide), 9.25 (d, 4JHH = 2.6 Hz, 2H, HPYA), 8.68 (dd, 
3JHH = 9.5 Hz, 4JHH = 2.6 Hz, 2H, HPYA), 8.50 (d, 3JHH = 7.8 Hz, 2H, Hpyr), 8.31 (t, 3JHH = 7.8 Hz, 1H, Hpyr), 
7.58 (d, 3JHH = 9.5 Hz, 2H, HPYA), 4.27 (s, 6H, NCH3), 4.05 (s, 6H, OCH3). HR ESI-MS (CH3CN) m/z 
calculated for [M–PF6]+ = 554.1386; found: 554.1387. Elemental Analysis: calculated for C21H23F12N5O4P2: 
C: 36.07; H: 3.31; N: 10.01; found: C: 36.37; H: 2.55; N: 9.92.	
Compound L2. According to the general procedure starting from 2,6-pyridinedicarbonyldichloride 
(611 mg, 3 mmol) and 5-amino-2-methylpyridine (811 mg, 7.5 mmol) in toluene (50 mL) giving the bis-
amide N2,N6-bis(6-methylypyridin-3-yl)pyridine-2,6-dicarboxamide as a purple powder (896 mg, 86%). 
Refluxing the bis-amide (347 mg, 1.0 mmol) in dry CH2Cl2 (30 mL) with MeOTf (0.33 ml, 3 mmol) for 
16 h gave L2 as OTf salt (605 mg, 85%). Reaction of this triflate salt (271 mg, 0.4 mmol) in MeCN (6 mL), 
with aqueous NH4PF6 (329 mg, 2.0 mmol) gave L2 as off white crystals (189 mg, 71%). 1H NMR (300 MHz, 
CD3CN, 298 K): d [ppm] = 10.52 (s, 2H, NHamide), 9.57 (d, 4JHH = 2.3 Hz, 2H, HPYA), 8.63 (dd, 3JHH = 8.8 
Hz, 4JHH = 2.3 Hz, 2H, HPYA), 8.53 (d, 3JHH = 7.7 Hz, 2H, Hpyr), 8.32 (t, 3JHH = 7.7 Hz, 1H, Hpyr), 7.91 (d, 
3JHH = 8.8 Hz, 2H, HPYA), 4.24 (s, 6H, NCH3), 2.75 (s, 6H, CH3). HR ESI-MS (CH3CN) m/z calculated for 
[M–PF6]+ = 522.1488; found: 522.1484. Elemental Analysis: calculated for C21H23F12N5O2P2: C: 37.79; H: 
3.47; N: 10.49; found: C: 37.53; H: 3.29; N: 10.10. 
Compound L4. According to the general procedure starting from 2,6-pyridinedicarbonyldichloride 
(611 mg, 3 mmol) and 5-amino-2-chloropyridine (960 mg, 7.5 mmol) in toluene (50 mL) giving the bis-
amide N2,N6-bis(6-chloroypyridin-3-yl)pyridine-2,6-dicarboxamide as a white powder (1013 mg, 87%). 
Refluxing the bis-amide (390 mg, 1.0 mmol) in dry CH2Cl2 (30 mL) with MeOTf (0.33 ml, 3 mmol) for 
16 h gave L4 as OTf salt (578 mg, 81%). Reaction of this triflate salt (359 mg, 0.5 mmol) in MeOH (36 mL) 
with solid NH4PF6 (818 mg, 5.0 mmol) L4 as a white powder, which was washed with small portions of 
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cold MeOH (257 mg, 74%). 1H NMR (300 MHz, CD3CN, 298 K): d [ppm] = 10.65 (s, 2H, NHamide), 9.75 
(d, 4JHH = 2.5 Hz, 2H, HPYA), 8.74 (dd, 3JHH = 9.1 Hz, 4JHH = 2.5 Hz, 2H, HPYA), 8.54 (d, 3JHH = 7.8 Hz, 2H, 
Hpyr), 8.37–8.32 (m, 1H, Hpyr), 8.15 (d, 3JHH = 9.1 Hz, 2H, HPYA), 4.39 (s, 6H, NCH3). HR ESI-MS (CH3CN) 
m/z calculated for [M–PF6]+ = 562.0396; found: 562.0406. Elemental Analysis: calculated for 
C21H17Cl2F12N5O2P2: C: 32.22; H: 2.42; N: 9.89; found: C: 32.29; H: 3.03; N: 9.65. 
Compound L5. According to the general procedure starting from 2,6-pyridinedicarbonyldichloride 
(310 mg, 1.5 mmol) and 5-amino-2-trifluoromethylpyridine (570 mg, 3.5 mmol) in toluene (25 mL) giving 
the bis-amide N2,N6-bis(6-trifluoromethylpyridin-3-yl)pyridine-2,6-dicarboxamide as a white powder 
(450 mg, 72%). Refluxing the bis-amide (300 mg, 0.66 mmol) in dry CH2Cl2 (40 mL) with MeOTf (0.22 
ml, 2 mmol) for 16 h gave L5 as OTf salt (479 mg, 93%). Reaction of this triflate salt (473 mg, 0.6 mmol) 
in MeCN (8 mL) with aqueous NH4PF6 (489 mg, 3.0 mmol) gave L5 as white needle-like crystals (415 mg, 
89%). 1H NMR (300 MHz, CD3CN, 298 K): d [ppm] = 10.86 (s, 2H, NHamide), 9.86 (d, 4JHH = 2.3 Hz, 2H, 
HPYA), 8.98 (dd, 3JHH = 8.9 Hz, 4JHH = 2.3 Hz, 2H, HPYA), 8.59 (d, 3JHH = 7.8 Hz, 2H, Hpyr), 8.50 (d, 3JHH = 
8.9 Hz, 2H, HPYA), 8.38 (t, 3JHH = 7.8 Hz, 1H, Hpyr), 4.55 (s, 6H, NCH3). HR ESI-MS (CH3CN) m/z calculated 
for [M–PF6]+ = 630.0923; found: 630.0910. Elemental Analysis: calculated for C21H17Cl2F12N5O2P2: C: 
32.53; H: 2.21; N: 9.03; found: C: 32.59; H: 1.79; N: 9.01. 
General procedure for the synthesis of complexes 1a–5a. The ligand L1–L5 (1 eq.), 
[RuCl2(cym)]2 (0.5 eq.) and Na2CO3 (3 eq.) were dissolved in MeCN and heated to reflux for 16 h. The 
reaction mixture was cooled to –18 °C for 2 h for quantitative precipitation, then filtered over Celite and the 
filtrate was concentrated to a saturated solution under reduced pressure. The crude product was precipitated 
from Et2O, filtered, washed with Et2O, and purified by gradient column chromatography.  
Complex 1a. According to the general procedure starting from L1 (595 mg, 0.85 mmol), 
[RuCl2(cym)]2 (260 mg, 0.43 mmol) and Na2CO3 (274 mg, 2.55 mmol) in MeCN (180 mL). Purification by 
gradient column chromatography (Al2O3; CH2Cl2/MeCN 1:1 to pure MeCN) gave 1a as dark orange powder 
(296 mg, 38%). 1H NMR (300 MHz, CD3CN, 298 K): d [ppm] = 8.49 (d, 4JHH = 2.5 Hz, 2H, HPYA), 8.44 
(dd, 3JHH = 9.3 Hz, 4JHH = 2.5 Hz, 2H, HPYA), 8.04–8.00 (m, 3H, Hpyr), 7.37 (d, 3JHH = 9.3 Hz, 2H, HPYA), 
4.21 (s, 6H, NCH3), 3.99 (s, 6H, OCH3), 2.48 (s, 3H, HMeCN(equ)), 2.13 (s, 6H, HMeCN(axial)). 13C{1H} NMR (75 
MHz, CD3CN, 298 K): δ [ppm] = 170.73 (C=O), 158.09 (Cpyr), 156.43 (Cpyr), 146.66 (CHpyr), 143.95 (Cpyr), 
139.55 (CHpyr), 136.82 (CHpyr), 128.20 (NCMe), 125.81 (CHpyr), 124.37 (NCMe), 110.12 (CHpyr), 59.64 
(O–CH3), 42.48 (N–CH3), 4.47 (NCCH3), 4.11 (NCCH3). HR ESI-MS (CH3CN) m/z calculated for [M–
PF6–MeCN]+ = 736.08043; found: 736.0809. Elemental Analysis: calculated for C27H30F12N8O4P2Ru: C: 
35.19; H: 3.28; N: 12.16; found: C: 35.06; H: 3.51; N: 12.09. 
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Complex 2a. According to the general procedure starting from L2 (154 mg, 0.24 mmol), 
[RuCl2(cym)]2 (71 mg, 0.12 mmol) and Na2CO3 (74 mg, 0.69 mmol) in MeCN (50 mL). No column 
chromatography was needed. Complex 2a was isolated as dark orange powder (170 mg, 83%). 1H NMR 
(300 MHz, CD3CN, 298 K): d [ppm] = 8.83 (d, 4JHH = 2.2 Hz, 2H, HPYA), 8.32 (dd, 3JHH = 8.7 Hz, 4JHH = 
2.5 Hz, 2H, HPYA), 8.08–8.03 (m, 3H, Hpyr), 7.69 (d, 3JHH = 8.7 Hz, 2H, HPYA), 4.15 (s, 6H, NCH3), 2.67 (s, 
6H, CH3), 2.47 (s, 3H, HMeCN(equ)), 2.13 (s, 6H, HMeCN(axial)). 13C{1H} NMR (75 MHz, CD3CN, 298 K): 
δ [ppm] = 170.95 (C=O), 157.90 (Cpyr), 150.06 (Cpyr), 148.27 (Cpyr), 143.21 (CHpyr), 142.72 (CHpyr), 136.96 
(CHpyr), 129.04 (CHpyr), 128.37 (NCMe), 126.20 (CHpyr), 124.62 (NCMe), 46.69 (N–CH3), 19.87 (CPYA–
CH3), 4.51 (NCCH3), 4.10 (NCCH3). HR ESI-MS (CH3CN) m/z calculated for [M–PF6–MeCN]+ = 
704.0906; found: 704.0936. Elemental Analysis: calculated for C27H30F12N8O2P2Ru ´ 0.25 CH2Cl2: C: 
35.93; H: 3.38; N: 12.30; found: C: 35.79; H: 3.90; N: 12.31. 
Complex 2b. To a solution of 2a (152 mg, 0.17 mmol) in EtOH (100 mL) was added PPh3 (52 mg, 
0.19 mmol) and the mixture was heated to reflux for 16 h. After cooling to RT, the solvent was removed 
under reduced pressure and the crude product was redissolved in a minimum amount of MeCN and 
precipitated from Et2O, filtered, and washed with copious amounts of Et2O. The residue was purified by 
gradient column chromatography (Al2O3; CH2Cl2/MeCN 1:1 to pure MeCN) to yield complex 2b as an 
orange powder (102 mg, 54%). 1H NMR (300 MHz, 298 K): d [ppm] = 8.24 (d, 4JHH = 2.2 Hz, 2H, HPYA), 
8.13 (dd, 3JHH = 8.5 Hz, 4JHH = 2.2 Hz, 2H, HPYA), 7.75 (t, 3JHH = 7.7 Hz, 1H, Hpyr), 7.75 (d, 3JHH = 8.5 Hz, 
2H, HPYA), 7.58 (d, 3JHH = 7.7 Hz, 2H, Hpyr), 7.29–7.24 (m, 3H, HPPh3), 7.03–6.99 (m, 6H, HPPh3), 6.95–6.90 
(m, 6H, HPPh3), 4.00 (s, 6H, NCH3), 2.72 (s, 6H, CH3), 2.58 (s, 3H, HMeCN(equ)), 2.12 (s, 3H, HMeCN(axial)). 
13C{1H} NMR (75 MHz, CD3CN, 298 K): δ [ppm] = 170.14 (C=O), 156.30 (Cpyr), 150.07 (CPYA), 148.37 
(CPYA), 144.15 (CHPYA), 142.97 (CHPYA), 136.76 (CHpyr), 133.45 (d, 2JCP = 9.9 Hz, CHPPh3), 132.61 (d, 1JCP 
= 44 Hz, CPPh3), 130.66 (d, 4JCP = 2.2 Hz, CHPPh3), 129.25 (CHPYA), 128.98 (d, 3JCP = 9.3 Hz, CHPPh3), 126.61 
(CHpyr), 46.51 (N–CH3), 19.97 (CPYA–CH3), 5.24 (NCCH3). 31P{1H} NMR (162 MHz, CD3CN, 298 K): d 
[ppm] = 51.86 (s, 1P, PPh3), –144.59 (septett, 1JPF = 709 Hz, 2P, PF6). HR ESI-MS (CH3CN) m/z calculated 
for [M–PF6–2MeCN]+ = 884.1286; found: 884.1320. Elemental Analysis: calculated for 
C43H42F12N7O2P3Ru ´ CH2Cl2: C: 44.20; H: 3.71; N: 8.20; found: C: 43.92; H: 3.42; N: 8.06. 
Complex 2c. To a solution of 2a (155 mg, 0.18 mmol) in EtOH (100 mL) was added dppe (80 mg, 
0.20 mmol) in EtOH (100 ml) and the mixture was stirred at reflux for 16 h. After cooling to RT, the solvent 
was removed under reduced pressure and the crude product was redissolved in a minimum amount of MeCN 
and precipitated from Et2O, filtered, and washed with copious amounts of Et2O. The residue was purified 
by gradient column chromatography (Al2O3; CH2Cl2/MeCN 1:1 to pure MeCN) to yield complex 2c as an 
orange powder (100 mg, 49%). 1H NMR (300 MHz, CD3CN, 298 K): d [ppm] = 8.41–8.37 (m, 1H, Hpyr), 
8.23–8.21 (m, 2H, Hpyr), 7.35–7.31 (m, 2H, HPPh), 7.29–7.17 (m, 14H, HPPh + HPYA), 7.10–7.04 (m, 6H, HPPh, 
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HPYA), 6.84–6.78 (m, 4H, HPPh, HPYA), 3.65 (s, 6H, N–CH3), 3.14–3.07 (m, 1H, CH2), 3.05–3.02 (m, 1H, 
CH2), 2.99–2.94 (m, 1H, CH2), 2.92–2.86 (m, 1H, CH2), 2.35 (s, 6H, CPYA–CH3). 13C{1H} NMR (75 MHz, 
CD3CN, 298 K): δ [ppm] = 171.55 (C=O), 154.45 (Cpyr), 150.81 (CPYA), 149.307 (CPYA), 143.70 (CHPYA), 
143.08 (CHPYA), 139.49 (CHpyr), 136.42 (d, 1JCP = 36 Hz, CPPh), 134.03 (d, 1JCP = 40 Hz, CPPh), 131.21 (d, 
JCP = 9.0 Hz, CHPPh), 131.05 (d, JCP = 8.1 Hz, CHPPh), 130.83 (d, JCP = 2.2 Hz, CHPPh), 129.89 (d, JCP = 
8.8 Hz, CHPPh), 129.68 (d, JCP = 2.3 Hz, CHPPh), 129.29 (d, JCP = 8.7 Hz, CHPPh), 129.14 (CHPYA), 126.83 
(CHpyr), 46.17 (N–CH3), 25.79–25.25 (m, CH2dppe), 23.97–23.54 (m, CH2dppe), 19.42 (CPYA–CH3). 31P{1H} 
NMR (162 MHz, CD3CN, 298 K): d [ppm] = 55.06 (d, 1JPP = 21 Hz, 1P, Pdppe), 54.47 (d, 1JPP = 21 Hz, 1P, 
Pdppe), –144.60 (hept, 1JPF = 707 Hz, 2P, PF6). HR ESI-MS (CH3CN) m/z calculated for [M–PF6–2MeCN]+ 
= 1020.1728; found: 1020.1758. Elemental Analysis: calculated for C49H48F12N6O2P4Ru ́  CH2Cl2: C: 46.52; 
H: 3.90; N: 6.51; found: C: 47.10; H: 3.71; N: 6.41.  
Complex 4a. According to the general procedure starting from L4 (107 mg, 0.15 mmol), 
[RuCl2(cym)]2 (47 mg, 0.075 mmol) and Na2CO3 (48 mg, 0.45 mmol) in MeCN (40 mL). Purification by 
gradient column chromatography (Al2O3; CH2Cl2/MeCN 1:1 to pure MeCN) gave 4a as red powder (90 mg, 
65%). 1H NMR (300 MHz, CD3CN, 298 K): d [ppm] = 9.02 (d, 4JHH = 2.5 Hz, 2H, HPYA), 8.40 (dd, 3JHH = 
9.0 Hz, 4JHH = 2.5 Hz, 2H, HPYA), 8.11–8.06 (m, 3H, Hpyr), 7.92 (d, 3JHH = 9.0 Hz, 2H, HPYA), 4.29 (s, 6H, 
NCH3), 2.51 (s, 3H, HMeCN(equ)), 2.13 (s, 6H, HMeCN(axial)). 13C{1H} NMR (75 MHz, CD3CN, 298 K): δ [ppm] 
= 171.21 (C=O), 157.48 (Cpyr), 151.07 (Cpyr), 145.06 (CHpyr), 144.18 (CHpyr), 138.30 (Cpyr), 137.16 (CHpyr), 
129.12 (CHpyr), 128.93 (NCMe), 126.66 (CHpyr), 124.94 (NCMe), 48.55 (N–CH3), 4.62 (NCCH3), 4.08 
(NCCH3). HR ESI-MS (CH3CN) m/z calculated for [M–PF6–MeCN]+ = 743.9814; found: 743.9805. 
Elemental Analysis: calculated for C25H24Cl2F12N8O2P2Ru: C: 32.27; H: 2.60; N: 12.04; found: C: 31.92; H: 
2.61; N: 11.85. 
Complex 5a. According to the general procedure starting from L5 (293 mg, 0.38 mmol), 
[RuCl2(cym)]2 (116 mg, 0.19 mmol) and Na2CO3 (120 mg, 1.14 mmol) in MeCN (100 mL). Purification by 
gradient column chromatography (Al2O3; CH2Cl2/MeCN 1:1 to pure MeCN) gave 5a as red powder 
(239 mg, 63%). 1H NMR (300 MHz, CD3CN, 298 K): d [ppm] = 9.24 (d, 4JHH = 2.3 Hz, 2H, HPYA), 8.51 
(dd, 3JHH = 8.9 Hz, 4JHH = 2.3 Hz, 2H, HPYA), 8.26 (d, 3JHH = 8.9 Hz, 2H, HPYA), 8.20–8.09 (m, 3H, Hpyr), 
4.42 (s, 6H, NCH3), 2.55 (s, 3H, HMeCN(equ)), 2.14 (s, 6H, HMeCN(axial)). 13C{1H} NMR (75 MHz, CD3CN, 
298 K): δ [ppm] = 171.88 (C=O), 157.12 (Cpyr), 155.78 (Cpyr), 148.35 (CHpyr), 141.44 (CHpyr), 137.48 
(CHpyr), 131.73 (CF3, q, 1JCF = 36.7 Hz), 129.60 (NCMe), 127.74 (Cpyr, q, 2JCF = 4.9 Hz), 127.41 (CHpyr), 
125.46 (CHpyr), 122.02 (NCMe), 48.26 (N–CH3), 4.76 (NCCH3), 4.10 (NCCH3). HR ESI-MS (CH3CN) m/z 
calculated for [M–PF6–MeCN]+ = 812.0341; found: 812.0371. Elemental Analysis: calculated for 
C27H24F18N8O2P2Ru: C: 32.51; H: 2.43; N: 11.23; found: C: 32.44; H: 1.98; N: 10.71. 
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General Procedure for Catalytic Transfer Hydrogenation. In a 20 mL pressure tube, a mixture 
of the complex, 2 molequiv PPh3 and hexamethylbenzene as internal standard were dissolved in iPrOH (5 
mL). This solution was degassed with N2 for 10 min. A degassed solution of the ketone substrate in iPrOH 
(1 M) was added via syringe and the solution was heated to 70 °C for 10 min. The catalytic reaction was 
started by injection of KOH (2 M solution in H2O) and heated to reflux in an oil bath (110 °C). Aliquots 
(ca. 0.1 ml) were taken at set times, and quenched by dissolving into CDCl3 for 1H NMR analysis. 
Conversions were determined relative to hexamethylbenzene as internal standard and correspond to 
spectroscopic yields. 
Crystal structure determination. Suitable single crystals of 1a and 5a were mounted in air at 
ambient conditions and measured on an Oxford Diffraction SuperNova area-detector diffractometer[57] using 
mirror optics monochromated Mo Kα radiation (λ = 0.71073 Å) and Al filtered.[58] The unit cell constants 
and an orientation matrix for data collection were obtained from a least-squares refinement of the setting 
angles of reflections. Data reduction was performed using the CrysAlisPro[57] program. The intensities were 
corrected for Lorentz and polarization effects, and a numerical absorption correction based on Gaussian 
integration over a multifaceted crystal model was applied. Data collection and refinement parameters are 
given in the SI. The structure was solved by direct methods using SHELXT[59], which revealed the positions 
of all non-hydrogen atoms of the title compounds. The non-hydrogen atoms were refined anisotropically. 
All H-atoms were placed in geometrically calculated positions and refined using a riding model where each 
H-atom was assigned a fixed isotropic displacement parameter with a value equal to 1.2Ueq of its parent 
atom (1.5Ueq for methyl groups and water). Refinement of the structure was carried out on F2 using full-
matrix least-squares procedures, which minimized the function Σw(Fo2 – Fc2)2. The weighting scheme was 
based on counting statistics and included a factor to downweight the intense reflections. All calculations 
were performed using the SHELXL-2014/7[60] program in OLEX2.[61] The crystal of 1a contains two co-
crystallized acetonitrile solvent molecules and 0.173 co-crystallized water molecules per asymmetric unit. 
The crystal of 5a contains one co-crystallized acetonitrile solvent molecule per asymmetric unit. Further 
crystallographic details are compiled in Tables S4 and S5. Crystallographic data for all structures have been 
deposited with the Cambridge Crystallographic Data Centre (CCDC) as supplementary publication numbers 
1986022 (1a) and 1986021 (5a). 
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